# Efficacy and Safety of Broncho-Vaxom in the First Episode of Pediatric Idiopathic Nephrotic Syndrome

> **NCT05044169** · NA · UNKNOWN · sponsor: **Fang Deng** · enrollment: 83 (estimated)

## Conditions studied

- Nephrotic Syndrome in Children

## Interventions

- **DRUG:** Broncho-Vaxom

## Key facts

- **NCT ID:** NCT05044169
- **Lead sponsor:** Fang Deng
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-09
- **Primary completion:** 2023-09
- **Final completion:** 2023-12
- **Target enrollment:** 83 (ESTIMATED)
- **Last updated:** 2021-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05044169

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05044169, "Efficacy and Safety of Broncho-Vaxom in the First Episode of Pediatric Idiopathic Nephrotic Syndrome". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05044169. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*